Conversely, the regulation of SPON2 by Notch has thus far been described in gastric cancer, while Notch signaling in prostate cancer is context-dependent, with both oncogenic and tumor-suppressive roles reported. This evidence concerns the gene SPON2 and prostate carcinoma.